¿Maykʼajllapis kay onqoy rikhurinchu?
Kay cáncer de próstataqa, qharispi astawan rikhurin, astawanraq machu runaspi.
Kay Sociedad Americana del Cáncer nisqap nisqanmanjina, próstata unquyqa, kay Estados Unidospi kaq qharispi, iskay kaq kaq unquyjina, qara unquymanta qhipa.
Estados Unidospi, sapa 9 qharismanta ujninman, próstata cancerwan unqusqankuta ninku.
Kay 2021 watapi, kay cancermanta 248.530 unquykuna rikhurinqa, 34.130 wañuypis kanqa.
Chaywanpis, chay onqoytaqa usqhayllata sanoyachiyta atisunman.
['Qillqasqa']
PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html
RefinedWeb https://arxiv.org/abs/2306.01116
Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R: Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18 (3): 808-15.
Peng P, Gong YM, Bao PP, Ke JZ, Xiang YM, Zhang ML, Zheng Y: [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1056-9.
Delongchamps NB, Singh A, Haas GP: The role of prevalence in the diagnosis of prostate cancer. Cancer Control. 2006, 13 (3): 158-68.
Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E: Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012, 36 (2): 122-7.
Yu XQ, Luo Q, Smith DP, Clements MS, O'Connell DL: Prostate cancer prevalence in New South Wales Australia: a population-based study. Cancer Epidemiol. 2015, 39 (1): 29-36.
Ondrusova M, Mrozova L, Ondrus D, Mrinakova B: Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012. Neoplasma. 2013, 60 (4): 446-51.
['Mana allinchu: unquy']
['Kay páginaqa, mana doctorman willanallapaqchu, nitaj ima unquymantapis jampichikunallapaqchu.']
['Kaypi willakusqanqa, mana unquykunata, unquykunata ima, yachanapaqchu, manaqa, unqusqasta yanapanapaq.']
['Kay tapuykunaman kutichiykunata churanapaq red neuronalqa, mana chiqanchu kachkan, chantapis yupaykunawan churanakun.']
["Kay sitio web nisqaqa mana ima unquymantapis jampichikunchu. BioMedLib, llamk'aqninkuna, manaqa kay sitio web nisqaman llamk'aqkuna, mana ima willaytapis, sut'ita chayri mana sut'ita, kaypi kaq willaykunata, apaykachayta ima, willankuchu."]
['Amachasqa: copyright']
['Kay Ley de Derechos de Autor del Milenio Digital de 1998, 17 U.S.C. § 512 (la DMCA) kamachiyqa, derechos de autorniyuqkunata, Internetpi kaqkuna, derechos de autor nisqata pʼakikusqankuta yuyaqkunata, jarkʼan.']
["Sichus allin yuyaywan yuyanki kay webpi utaq kay llamk'aykunapi ima qillqapas utaq ima llamk'achisqapas derechosniykita p'akikusqanta chayqa, qan (utaq wakichiqniykim) willawasunman chay qillqata utaq llamk'achisqata chinkachinanchikpaq utaq hark'ananchikpaq."]
['Kay willaykunataqa, qillqasqa, correo electrónico nisqapi apachina tiyan (contacto nisqapi, correo electrónico nisqapi qhaway).']
["DMCA kamachiypi nin, kay willañiqiman kaykunata churanan tiyan: 1) chay llamk'aypa sutinta, 2) chay llamk'aypa sutinta, imachus chay llamk'aypi kachkan chaymanta ima, 3) chay llamk'aypa maypi kasqanta, maymanchus kachkasqanta, imachus chay llamk'aypi kachkan chaymanta ima, 4) chay llamk'aypa sutinta, maymanchus kachkasqanta, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima, imachus chay llamk'aypi kachkan chaymanta ima."]
['(5) willayniykipi, mana chiqaqta willasqaykita, willayniykipi willasqaykikuna chiqap kasqanta, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis, chaymantapis.']
['Kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi, kaypi.']
['Mana tukuy kaykunata qillqaspaqa, mana usqhayllatachu kutichisunqa.']
How common is prostate cancer?
Prostate cancer is one of the most common types of cancer in men, particularly in older men.
According to the American Cancer Society, prostate cancer is the second most common cancer in American men, behind skin cancer.
In the United States, about 1 in 9 men will be diagnosed with prostate cancer during their lifetime.
In 2021, it is estimated that there will be about 248,530 new cases of prostate cancer and about 34,130 deaths from prostate cancer.
However, it is important to note that prostate cancer is highly treatable, and the survival rate is high when it is detected early.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
